Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M; European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Bartelink H, et al. Among authors: fourquet a. N Engl J Med. 2001 Nov 8;345(19):1378-87. doi: 10.1056/NEJMoa010874. N Engl J Med. 2001. PMID: 11794170 Free article. Clinical Trial.
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
Solin LJ, Fourquet A, McCormick B, Haffty B, Recht A, Schultz DJ, Barrett W, Fowble BL, Kuske R, Taylor M, et al. Solin LJ, et al. Among authors: fourquet a. Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9. doi: 10.1016/0360-3016(94)90512-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 8083125 Clinical Trial.
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
Solin LJ, Yeh IT, Kurtz J, Fourquet A, Recht A, Kuske R, McCormick B, Cross MA, Schultz DJ, Amalric R, et al. Solin LJ, et al. Among authors: fourquet a. Cancer. 1993 Apr 15;71(8):2532-42. doi: 10.1002/1097-0142(19930415)71:8<2532::aid-cncr2820710817>3.0.co;2-0. Cancer. 1993. PMID: 8384070
Postmastectomy radiotherapy: questions for the twenty-first century.
Recht A, Bartelink H, Fourquet A, Fowble B, Haffty BG, Harris JR, Kurtz J, McCormick B, Olivotto IA, Rutqvist L, Solin LJ, Yarnold J. Recht A, et al. Among authors: fourquet a. J Clin Oncol. 1998 Aug;16(8):2886-9. doi: 10.1200/JCO.1998.16.8.2886. J Clin Oncol. 1998. PMID: 9704743 No abstract available.
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Van der Hulst M, Van der Schueren E, Bartelink H. Vrieling C, et al. Among authors: fourquet a. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):677-85. doi: 10.1016/s0360-3016(99)00211-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10524422 Clinical Trial.
Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation.
Ptaszynski AM, Van den Bogaert W, Horiot JC, Poortmans P, Fourquet A, Struikmans H, Bartelink H, Pierart M, Collette L, van der Schueren E. Ptaszynski AM, et al. Among authors: fourquet a. Acta Oncol. 1999;38 Suppl 13:19-27. doi: 10.1080/028418699432725. Acta Oncol. 1999. PMID: 10612492 Clinical Trial.
332 results